Kaneka Logo
Health Care Providers PhotoFor Health Care Professionals


The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma of the following high risk patient populations for whom diet has been ineffective and maximum drug therapy has either been ineffective or not tolerated:

Group A:

Functional Hypercholesterolemic Homozygotes with LDL-C > 500 mg/dL;

Group B:

Functional Hypercholesterolemic Heterozygotes with LDL-C ≥ 300 mg/dL; and

Group C:

Functional Hypercholesterolemic Heterozygotes with LDL-C ≥ 160 mg/dL and either documented coronary heart disease or documented peripheral arterial disease.

KANEKA MA-03 PA2 Apheresis Machine Operation


© Copyright Kaneka Pharma America, LLC . All rights reserved.

The information on this site is intended for U.S. residents only.